University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Clinical effectiveness and cost-effectiveness of imatinib dose escalation for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours that have progressed on treatment at a dose of 400 mg/day : a systematic review and economic evaluation

Simple item page
dc.contributor.authorHislop, J
dc.contributor.authorQuayyum, Z
dc.contributor.authorElders, A
dc.contributor.authorFraser, C
dc.contributor.authorJenkinson, D
dc.contributor.authorMowatt, G
dc.contributor.authorSharma, P
dc.contributor.authorVale, L
dc.contributor.authorPetty, R
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Applied Medicineen
dc.date.accessioned2011-09-13T14:05:05Z
dc.date.available2011-09-13T14:05:05Z
dc.date.issued2011
dc.description.statusPeer revieweden
dc.format.extent178
dc.format.extent1615273
dc.identifier6635190
dc.identifier8a015860-943a-4185-9600-b38868afb5bd
dc.identifier21689502
dc.identifier79960807465
dc.identifier.citationHislop, J, Quayyum, Z, Elders, A, Fraser, C, Jenkinson, D, Mowatt, G, Sharma, P, Vale, L & Petty, R 2011, 'Clinical effectiveness and cost-effectiveness of imatinib dose escalation for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours that have progressed on treatment at a dose of 400 mg/day : a systematic review and economic evaluation', Health Technology Assessment, vol. 15, no. 25, pp. 1-178. https://doi.org/10.3310/hta15250en
dc.identifier.doi10.3310/hta15250
dc.identifier.iss25en
dc.identifier.issn2046-4924
dc.identifier.urihttp://hdl.handle.net/2164/2123
dc.identifier.vol15en
dc.language.isoeng
dc.relation.ispartofHealth Technology Assessmenten
dc.subjectR Medicineen
dc.subjectChief Scientist Office (CSO)en
dc.subjectCSO--HERU2en
dc.subjectCSO--HSRU1en
dc.subject.lccRen
dc.titleClinical effectiveness and cost-effectiveness of imatinib dose escalation for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours that have progressed on treatment at a dose of 400 mg/day : a systematic review and economic evaluationen
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Hislop_2011.pdf
Size:
1.54 MB
Format:
Adobe Portable Document Format
Download

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
8.29 KB
Format:
Plain Text
Description:
Download

Collections

All research
Applied Health Sciences research
Applied Medicine research
University Office research